LATEST ALERTS
Reform of cannabis laws at federal level in the US looks to be a step closer following the likely victory of the Democratic party in run-off elections for both Senate seats in the state of Georgia
South Dakota’s governor has put public cash behind a legal challenge to a move – backed by a majority of voters – to legalise recreational cannabis in the US state. But can the lawsuit overturn the vote?
Further CBD regulations in the US could be based on rules proposed in the state of New York, it has been suggested – especially crucial definitions for some key terms
For many 2020 will always carry an asterisk. The CBD industry was – overall – more fortunate than many other sectors
Multiple jurisdictions are planning significant legislation on both CBD and hemp-related matters, but it seems regulation in 2021 could be defined as much by what doesn’t happen as by the progress made
Efforts to supply the first CBD product to Brazil’s public healthcare system will have to wait a while longer – and there is some dispute between the institute preparing to produce it and the sponsors of a Congress bill
This week’s regulatory news in brief includes updates from the UE, Iceland, Ireland, Italy, Lithuania, the UK, Ukraine, the US, Australia and Thailand
This week’s regulatory news in brief includes updates from Belgium, France, Ireland, Italy, Netherlands, Switzerland, Bermuda, the British Virgin Islands, Canada, Guam, the US, Australia, Brazil, Philippines, Thailand and Uzbekistan
Cannabis legalisation is so far away in Russia that the plant is now considered a national security threat, according to provisions of the new state strategy for Anti-Drug Policy.
The Italian Customs Agency is trying to widen its jurisdiction by proposing including the sale of CBD hemp flowers within the state monopoly. Others have similar ideas
A proposed amendment to Polish law would ban the sale of CBD products through vending machines – but one company using that distribution method does not see any reason to stop just yet
CBD is considered a medicine in Cyprus and any CBD-infused product would be classified as a medicinal product. The report covers the current regulatory regime in place
The implications of the Kanavape ruling could be far-reaching. This report examines the decision by the Court of Justice of the European Union (CJEU) and some of its likely consequences
This week’s regulatory news in brief includes updates from North Macedonia, Switzerland, Mexico, the US, British Virgin Islands, Ecuador, Israel, New Zealand and Thailand
The European Parliament will have a united position on hemp-related issues during the ongoing tripartite negotiations, which must be concluded by the end of March
The Court of Justice of the European Union’s (CJEU) decision in the Kanavape case will have a tremendous impact on the CBD industry in the European Union (EU). However, the breadth of its impact is not yet fully realised. A number of things must happen beforehand and it may come down to further court rulings before a baseline level of requirements and » Continue Reading.
This report provides a detailed overview of the current regulatory regime in place for hemp and CBD in Ecuador, as well as information on medical and recreational cannabis
Cannabis, THC and CBN are controlled substances in Ireland under the Misuse of Drugs Act, but CBD and CBG are not. This report offers an overview of the current regime in Ireland
A move to legalise cannabis in the US state of Montana, backed by a substantial majority in last month’s ballot, is under threat from a legal bid to block it
This week’s regulatory news in brief includes updates from Belgium, Cyprus, the EU, Denmark, France, Ireland, Italy, Slovakia, Spain, the US, Colombia, Costa Rica, New Zealand and Thailand
The European Commission (EC) will start to review novel food applications after reversing its opinion on the narcotic status of CBD, the EC has confirmed to CBD-Intel
The announcement is a full reversal from the EC on a position that many found surprising in the first place. It marks a stellar period for the regulation of CBD and other cannabinoids with major decisions in their favour at the Court of Justice of the European Union, United Nations and now the EC. The resumption of novel food assessment » Continue Reading.
The United Nations (UN) vote on various cannabis related proposals has largely been seen as a historic moment symbolically but one that can only be considered a tiny first step in practical terms
This report sets out to guide you through the legal status and classification of two of the most popular cannabinoids, after CBD and THC, in 50 selected countries
A CBD shop in the town of Glastonbury in southwest England has been called out for publishing anti-mask advertisements
One of four proposed changes to the international scheduling of cannabis as well as CBD has been passed by the 53 voting members of the United Nations Commission on Narcotic Drugs (CND)
The Isle of Man looks likely to become the second jurisdiction operating under UK regulations to allow the use of hemp flowers in extraction
The following is a historical compilation of the updates to the US CBD delta-8 tracker from June 2022 to present. Click on each date to expand the list of updates for that month.
Italian legislators have put forward another proposal that has yet to be presented as an amendment to regulate the CBD sector and, in particular, the sale of flowers, finished products and extracts
This week’s regulatory news in brief includes updates from the EU, Belgium, France, Germany, Italy, Lithuania, Netherlands, Poland, Spain, the US, Israel, South Africa, Thailand and Zimbabwe
Overall it seems the industry – particularly in Europe – is not expecting much from Black Friday sales. European companies appear to consider CBD products more as health products that are requirement purchases throughout the year as opposed to lifestyle products that might be purchased as a one off during a special sales event. The situation may be slightly different in the US where Black Friday – » Continue Reading.
Officials in Malawi have been accused of deliberately setting high licence fees for hemp and cannabis cultivation and trade in order to attract international investment and exclude local ownership
Starting next year, Switzerland will allow the commercial growing of all hemp varieties with a THC content below 1% – even those that are not in the European Union catalogue
Voters in the US states of Arizona, Mississippi, Montana, New Jersey, and South Dakota passed ballot initiatives to legalise adult-use and/or medical cannabis in their states. However, the path from ballot initiative to law is not always clear
This week’s regulatory news in brief includes updates from the EU, Czech Republic, France, Netherlands, Spain, Switzerland, the UK, Mexico, the US, Cayman Islands, Brazil, China Costa Rica and Namibia
How important is the CJEU decision on the Kanavape case? The judgement in favour of CBD from the Courts of Justice of the European Union (CJEU) will almost certainly have significant long-term consequences for the CBD industry in Europe. It will likely influence the European Commission (EC)’s further assessment of the question of whether CBD is a narcotic. The preliminary opinion » Continue Reading.
Berta Camps Bisbal, CBD-Intel’s senior legal analyst, presented a comparative analysis of state laws in the US at CBD Live during VOXPO – Virtual Online Vape & CBD Expo on 18th November. She presented an overview of the federal farm bill as well as CBD at the federal level versus state level. You can now watch her presentation to obtain » Continue Reading.
The Italian regulatory landscape differentiates between hemp and cannabis. This report offers a detailed overview of the current regime for CBD as well as for medical and recreational cannabis
Mexico is overall the number one country to watch, rated highly likely to change regulations on both medical and recreational cannabis in the near future.
This week’s regulatory news in brief includes updates from the EU, Germany, Belgium, Spain, the UK, Mexico, the US, Argentina, Colombia, Costa Rica, Israel and Ukraine
Ukraine has undergone a quick shift in opinion on medical cannabis – proceeding from a point where liberalisation of current laws was viewed as unlikely to setting up parliamentary working groups to draft a bill on legalisation
The US Food and Drug Administration (FDA) may be open to allowing CBD as an ingredient in dietary supplements as well as in food and drink products. However, the regulatory pathway is not clear
Singapore has a tough regime for hemp products. This report offers an overview of said regime, covering all areas of law
The Italian Ministry of Health has suspended the recently published decree listing oral administration of CBD as a medicine under Italy’s Narcotics Law
This week’s regulatory news in brief includes updates from France, Germany, Lithuania, the UK, the US, Argentina, Australia, China, Costa Rica, Guyana, Israel, New Zealand, Panama, Russia and Uruguay
Concerns over traceability, limiting final use and demonstrating safety of final products could make it difficult to grant UK novel food approval to CBD ingredients producers and white label manufacturers
This report provides an overview of the recreational cannabis and CBD market in Canada in relation to the provincial regulations in place across the country
It looks like a clean sweep for pro-cannabis referendums in US states. But much work will still need to be done with state legislatures having to design and pass regulatory structures for each measure
One in three US citizens will soon be living in states where recreational cannabis is legal, while around 70% will have access to some form of medical cannabis programme after voters had their say
There is currently no specific national legislation in Greece relating to CBD, nor are there any restrictions that could prohibit the sale and import of CBD isolates, provided that the CBD source complies with relevant laws
Stay up-to-date with key market trends and regulatory news and receive complimentary data on a regular basis.
"*" indicates required fields
Get 7 days of access to industry updates through our news analysis and regulatory alerts
"*" indicates required fields
